+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Invega"

Schizophrenia Market Report 2025 - Product Thumbnail Image

Schizophrenia Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
From
From
From
Drug Overview: Invega Sustenna/Invega Trinza - Product Thumbnail Image

Drug Overview: Invega Sustenna/Invega Trinza

  • Report
  • March 2018
  • 20 Pages
  • Global
From
  • 10 Results (Page 1 of 1)
Loading Indicator

Invega is a brand of antipsychotic medication used to treat mental disorders such as schizophrenia, bipolar disorder, and major depressive disorder. It is a long-acting form of the drug paliperidone, which is a dopamine antagonist. Invega is manufactured by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. It is available in both oral and injectable forms. Invega is one of the leading medications in the mental disorders drugs market. It is used to treat a wide range of mental health conditions, including schizophrenia, bipolar disorder, and major depressive disorder. It is also used to treat symptoms of psychosis, such as hallucinations and delusions. Invega is generally well-tolerated and has few side effects. The Invega market is highly competitive, with several major pharmaceutical companies competing for market share. These include Janssen Pharmaceuticals, Pfizer, Eli Lilly, AstraZeneca, and Novartis. Each of these companies has its own range of products, including generic versions of Invega, as well as other antipsychotic medications. Show Less Read more